News
Lilly wins new FDA approval for eczema drug Ebglyss
Lilly's Ebglyss has claimed an FDA approval for less-frequent maintenance dosing that could give it an edge over market leader Dupixent.
News
Bayer's asundexian starts EU review for ischaemic stroke
The EMA has started its review of Bayer's asundexian for secondary stroke prevention, keeping it ahead of a rival drug from BMS and J&J.
News
GSK pursues $10.6bn takeover of cancer biotech Nuvalent
GSK is preparing for its biggest acquisition in more than 10 years, agreeing to buy cancer drug developer Nuvalent for $10.6 billion.
Sales & Marketing
Are pharma teams ready for the next customer engagement mode...
The infrastructure is largely in place.
News
SCOTUS backs generic firm Hikma in skinny label dispute
SCOTUS has delivered its ruling in a closely watched 'skinny label' lawsuit between Amarin and Hikma, which could have far-reaching implications.
News
Press Releases
Views & Analysis
Editor's Picks
Editor's Picks
